Breast cancer screening by clinical breast examination is a viable approach in low and middle income countries, suggests an Indian cluster randomized controlled trial.
The CLEAR study has demonstrated a significant progression-free survival gain with use of lenvatinib plus pembrolizumab for the first-line treatment of advanced clear cell renal cell carcinoma.
The Taiwan Lung Cancer Screening in Never-Smoker Trial suggests that low-dose computed tomography screening may help to detect early-stage disease in never smokers at high risk for developing lung cancer.
Patients receiving antitumor treatments may have a higher risk for acquiring SARS-CoV-2 infection than the general population, but overall the incidence appears to be low, say Italian researchers.